Glucotrack stockholders approve 150M share increase and reverse split authorization

Glucotrack, Inc.

Authorized common stock increased from 100M to 250M shares; amendment filed and effective Jan 3, 2025.
Reverse stock split authorized at ratio between 1-for-2 and 1-for-20; board to decide timing and ratio.
Issuance of shares upon exercise of Series A and Series B warrants approved (1,339,424 for, 12,157 against).
Special meeting quorum was 36.1%; adjournment proposal not needed as all proposals passed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Glucotrack, Inc.: Amended Certificate of Incorporation to increase authorized common stock from 100,000,000 to 250,000,000 shares (effective 2025-01-03).

Change: charter amendment
Effective: 2025-01-03

Exact text from the filing

the Company filed the Certificate of Amendment with the Secretary of State of the State of Delaware, and such amendment became effective immediately.

View on SEC.gov

8 governance changes filed in the last 30 days. Browse all governance changes →

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-001222

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.